SPC
INSP icon

Slate Path Capital’s Inspire Medical Systems INSP Stock Holding History

Slate Path Capital’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-294,000
Closed -$59.8M – 70
2023
Q4 		$59.8M Buy
+294,000
New +$47.6M 1.33% 28

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Slate Path Capital's INSP Position: Q1 2024 in Review

Slate Path Capital sold out of Inspire Medical Systems (INSP) in Q1 2024, closing a stake of 294,000 shares — an estimated $59.8M sold.

Slate Path Capital first reported a position in INSP in Q4 2023 and held it in 1 quarter. The position peaked at $59.8M in Q4 2023. 328 funds tracked by Wall St. Rank hold INSP as of Q1 2024.

  • Slate Path Capital reported no remaining Inspire Medical Systems position as of Q1 2024 after selling out during the quarter.
  • Slate Path Capital sold 294,000 Inspire Medical Systems shares in Q1 2024, an estimated $59.8M.
  • Slate Path Capital first reported a position in Inspire Medical Systems in Q4 2023 and held it in 1 quarter.
  • Slate Path Capital's Inspire Medical Systems position peaked at $59.8M in Q4 2023.
  • 328 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2024.

Based on Slate Path Capital's 13F filing for Q1 2024, filed 15 May 2024.